Biogen (BIIB) News Today → Biden out June 13? (From Paradigm Press) (Ad) Free BIIB Stock Alerts $219.40 +0.09 (+0.04%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSpotlight on Biogen: Analyzing the Surge in Options Activitybenzinga.com - March 18 at 7:39 PM25 Most Stressed Cities in the United Statesfinance.yahoo.com - March 18 at 2:39 PMGateway Investment Advisers LLC Has $12.15 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 18 at 8:41 AMBiogen Inc. (NASDAQ:BIIB) Short Interest Down 9.7% in Februarymarketbeat.com - March 18 at 12:48 AMFirst Week of May 17th Options Trading For Biogen (BIIB)nasdaq.com - March 17 at 11:30 PMEisai: All About Lenvima And Leqembiseekingalpha.com - March 17 at 6:29 PMDiversified Trust Co Takes Position in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 17 at 6:37 AMBoston Common Asset Management LLC Has $15.19 Million Position in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 16 at 4:09 PMBIIB Mar 2024 300.000 callca.finance.yahoo.com - March 16 at 10:35 AM$10 Biotech Stock Wall Street Says Will Be Up Over 200% This Year247wallst.com - March 15 at 9:11 AM38,079 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by Comerica Bankmarketbeat.com - March 15 at 5:18 AMABCL Oct 2024 6.000 callfinance.yahoo.com - March 15 at 12:18 AMBiogen Inc. (BIIB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoingsbusinesswire.com - March 14 at 7:31 PMHudson Bay Capital Management LP Increases Stock Position in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 13 at 10:42 AMBanque Pictet & Cie SA Has $6.17 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 12 at 11:16 AMMorgan Stanley Acquires 61,814 Shares of Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 12 at 7:42 AMRecent Alzheimer's disease dynamics are a positive for Biogen's Leqembi - Oppenheimerca.investing.com - March 11 at 4:17 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIBprnewswire.com - March 11 at 3:21 PMPolar Capital Holdings Plc Lowers Stock Holdings in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 11 at 1:49 PMAbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditionsfinance.yahoo.com - March 11 at 9:28 AMPublic Employees Retirement System of Ohio Sells 9,094 Shares of Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 9 at 10:18 AMFDA delays approval deadline for Eli Lilly's Alzheimer's drugfinance.yahoo.com - March 8 at 9:00 PMEli Lilly Alzheimer’s Drug Delayed as FDA Plans Advisory Panel Meetingfinance.yahoo.com - March 8 at 10:56 AMAre These 5 Undervalued Stocks Ready to Break Out? (BIIB)marketbeat.com - March 8 at 9:10 AMAdage Capital Partners GP L.L.C. Sells 341,161 Shares of Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 8 at 7:27 AMBiogen Alzheimer’s drug off to a slower rollout in U.S., partner Eisai saysmsn.com - March 7 at 1:18 PMTruist Financial Corp Has $13.26 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 7 at 6:58 AMBiogen Highlights New Data at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD(TM)) 2024 Annual Meetingstockhouse.com - March 6 at 5:16 PMRBC Capital Keeps Their Buy Rating on Biogen (BIIB)markets.businessinsider.com - March 6 at 5:16 PMBiogen's Spinraza For Muscle Movement Disorder Shows Improved Motor Function In Infants, Toddlersbenzinga.com - March 6 at 5:16 PMBiogen Inc. (NASDAQ:BIIB) Shares Sold by Krensavage Asset Management LLCmarketbeat.com - March 6 at 12:20 PMNew Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapyglobenewswire.com - March 6 at 7:30 AMA Closer Look at 21 Analyst Recommendations For Biogenmarkets.businessinsider.com - March 5 at 1:12 PMGlenmede Trust Co. NA Sells 58,328 Shares of Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 5 at 10:59 AMBiogen Q4 Earnings Transcriptmarketbeat.com - March 5 at 7:01 AMBiogen Inc.: Biogen Highlights New Data at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) 2024 Annual Meetingfinanznachrichten.de - March 4 at 8:56 PMBiogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual Meetingfinance.yahoo.com - March 4 at 8:56 PMBiogen Highlights New Data at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD™) 2024 Annual Meetingglobenewswire.com - March 4 at 4:15 PMBiotechs on the Rise: 3 Stocks to Buy for a Shot of Profitsinvestorplace.com - March 4 at 4:09 PMArrakis Therapeutics lays off 20% of its workforcebizjournals.com - March 4 at 3:56 PMBiogen Inc. (BIIB) TD Cowen 44th Annual Health Care Conference - (Transcript)seekingalpha.com - March 4 at 3:56 PMBiogen relying on success of Leqembi following discontinuation of Aduhelmmsn.com - March 4 at 10:55 AMBIIB Mar 2024 245.000 callfinance.yahoo.com - March 3 at 5:46 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIBprnewswire.com - March 3 at 10:15 AMAQR Capital Management LLC Sells 29,709 Shares of Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 3 at 9:25 AMBiogen Inc. (NASDAQ:BIIB) is Armistice Capital LLC's 6th Largest Positionmarketbeat.com - March 2 at 12:26 PM1 Wall Street Analyst Thinks Biogen Stock Is Going to $311. Is It a Buy Around $223?fool.com - March 2 at 10:27 AMIs Eli Lilly Stock A Buy On Projection For $81 Billion In Weight-Loss Sales?finance.yahoo.com - March 1 at 1:55 PMBiogen (NASDAQ:BIIB) Sets New 52-Week Low at $215.35marketbeat.com - March 1 at 11:03 AMBIIB Mar 2024 225.000 calluk.finance.yahoo.com - March 1 at 8:55 AM Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address RIP U.S. Dollar (04/1792 - 10/2024) (Ad)Mark Levin: Guard your money NOW Mark Levin has seen it all as America’s #1 political commentator. But he’s warning Americans that he’s never seen things this bad. Government spending threatens to destroy our economy. Reckless policies continue to fuel inflation and threaten the US Dollar. And it’s your retirement savings that could ultimately pay the price. Join this 100% free Wealth Summit to see how to protect yourself now. Register For The Free Summit Now BIIB Media Mentions By Week BIIB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.820.62▲Average Medical News Sentiment BIIB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼1716▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: American Electric Power News Today Neurocrine Biosciences News Today Repligen News Today Pinnacle West Capital News Today CRISPR Therapeutics News Today Portland General Electric News Today Denali Therapeutics News Today Gilead Sciences News Today Moderna News Today argenx News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaBiden out June 13?Paradigm PressMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.